Evidence-based·Updated November 20, 2026·How we grade evidence

Methylphenidate

MedicationStimulant for ADHD (prescription)

Methylphenidate improves core ADHD symptoms in children and adolescents and, to a lesser degree, in adults, based on large reviews of short-term trials, though one Cochrane review rated the certainty very low. Energy drinks, which add caffeine and other stimulants, and St. John's wort, for which the evidence is limited to a few adverse event reports, are the supplement and drink interactions in our database.

Taking Methylphenidate with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Children 6 and older, adolescents and adults with ADHD, and people with narcolepsy (Ritalin label), under a prescriber

Common dosing range

Set by a prescriber. The Ritalin label starts children 6 and older at 5 mg twice daily, and adults average 20 to 30 mg a day in 2 or 3 doses, with a maximum of 60 mg a day. Concerta starts at 18 mg once each morning in children and 18 or 36 mg in adults, up to 54 or 72 mg depending on age.

When to expect effects

Blood levels peaked on average about 2 hours after a 10 mg Ritalin tablet; trials measured symptom changes over days to about 12 weeks

Watch out for

Boxed warning for abuse, misuse and addiction, which can lead to overdose and death. Also raised blood pressure and heart rate, rare sudden death in people with serious heart problems, new psychotic or manic symptoms, slowed growth in children, painful prolonged erections, and dangerous blood pressure spikes with MAOIs (monoamine oxidase inhibitors).

What is it

Methylphenidate is a prescription central nervous system stimulant and a Schedule II controlled substance. It is used for attention deficit hyperactivity disorder (ADHD), and the immediate-release Ritalin label also approves it for narcolepsy. It comes in many forms: immediate-release tablets and solution (Ritalin, Methylin and generics), taken 2 or 3 times a day; long-acting tablets, capsules, chewables, liquids and dissolving tablets taken once a day (such as Concerta, Metadate CD, Quillivant XR, QuilliChew ER, Cotempla XR-ODT, Relexxii and Jornay PM, which is taken in the evening); and a skin patch (Daytrana). Concerta is approved for ADHD in people aged 6 to 65. Every methylphenidate label carries a boxed warning about abuse, misuse and addiction. This page focuses on the forms taken by mouth; the patch has some extra skin-related warnings noted below.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You or your child has a diagnosis of ADHD and a prescriber recommends methylphenidate after checking heart history and other risks (with a prescriber)
You have narcolepsy and your prescriber recommends immediate-release methylphenidate (with a prescriber)
You can keep caffeine and energy drinks modest and discuss any supplement with your prescriber or pharmacist (with a prescriber)

Probably skip if…

You take any MAOI (monoamine oxidase inhibitor) or have taken one in the last 14 days: the label says methylphenidate is contraindicated
You have serious structural heart disease or heart rhythm problems, unless a specialist has weighed the risk
You rely on energy drinks or high-dose caffeine products and do not want to cut back
You want to use it without a prescription to study or stay awake: the boxed warning describes abuse, overdose and death

Evidence at a glance

ADHD in children and adolescents

Limited Evidence
Effect
Moderate to large; standardized mean difference -0.78 on clinician ratings and -0.82 on teacher ratings vs placebo
Best fit
Children and adolescents with a diagnosis of ADHD
Time
Measured at about 12 weeks

ADHD in adults

Limited Evidence
Effect
Small to moderate; standardized mean difference -0.49 vs placebo on clinician ratings
Best fit
Adults with a diagnosis of ADHD
Time
Measured over about 6 to 18 weeks

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

ADHD in children and adolescents

Disease adjunct
Limited Evidence

A 2018 network meta-analysis of 133 double-blind randomized trials found that, at about 12 weeks, methylphenidate improved clinician-rated core ADHD symptoms in children and adolescents compared with placebo (standardized mean difference -0.78, rated moderate certainty), and it was one of only two medicines that beat placebo on teachers' ratings (-0.82, rated low certainty). It was not less well tolerated than placebo in this age group. The authors recommended methylphenidate as a first choice for short-term treatment in children and adolescents. There were not enough data to judge effects at 26 or 52 weeks. Reviews disagree on how certain these short-term results are: a 2025 Cochrane review rated the evidence very low certainty.

Effect size
Moderate to large; standardized mean difference -0.78 on clinician ratings and -0.82 on teacher ratings vs placebo
Time to effect
Measured at about 12 weeks
Best fit
Children and adolescents with a diagnosis of ADHD
Less likely
People looking for proof of long-term benefit, which these trials did not provide

Bottom line: In short-term trials, methylphenidate improved ADHD symptoms in children and adolescents, but reviews differ on how certain that evidence is (a 2025 Cochrane review rated it very low), and long-term evidence is thin.

Evidence is mixed

A 2025 Cochrane review of 212 trials (16,302 children and adolescents, mean age 9.8, mean treatment 28.8 days) also found improved teacher-rated symptoms (about 10.58 points on a 0 to 72 scale, above the 6.6-point minimal important difference) but rated the certainty of every outcome very low, because 191 of 212 trials were at high risk of bias and side effects make blinding hard. It found more non-serious side effects such as sleep problems and decreased appetite, and no clear effect on quality of life.

ADHD in adults

Disease adjunct
Limited Evidence

In the same 2018 network meta-analysis, methylphenidate improved clinician-rated ADHD symptoms in adults compared with placebo (standardized mean difference -0.49), a smaller effect than in children, and adults stopped it because of side effects more often than placebo (odds ratio 2.39). A 2021 Cochrane review limited to immediate-release methylphenidate in adults (10 trials, 497 people, 6 to 18 weeks) found only low- to very low-certainty evidence of benefit, with more stomach problems and loss of appetite than placebo.

Effect size
Small to moderate; standardized mean difference -0.49 vs placebo on clinician ratings
Time to effect
Measured over about 6 to 18 weeks
Best fit
Adults with a diagnosis of ADHD
Less likely
Adults who cannot tolerate stimulant side effects such as loss of appetite and stomach upset

Bottom line: Methylphenidate helps adult ADHD symptoms less than it helps children's, and the evidence for immediate-release forms in adults is uncertain.

Evidence is mixed

The network meta-analysis found a clear benefit in adults, while the Cochrane review of immediate-release methylphenidate found no certain evidence of benefit, mainly because of few, small, high-risk-of-bias trials.

How it works

Methylphenidate blocks the reuptake of the brain messengers norepinephrine and dopamine and increases their release, which raises their levels between nerve cells. In ADHD this improves attention and reduces hyperactivity and impulsive behavior. Like other stimulants, it also raises blood pressure (on average about 2 to 4 mmHg) and heart rate (about 3 to 6 beats per minute), according to the label. The labels say methylphenidate is broken down mainly by de-esterification to an inactive metabolite (ritalinic acid); the Metadate CD label adds that this is done by esterase enzymes widely distributed throughout the body and that, in lab studies, methylphenidate was not metabolized by cytochrome P450 enzymes. So its interactions are mostly about added stimulation rather than enzyme changes. This is why caffeine and energy drinks matter: they push heart rate, blood pressure and alertness in the same direction. Alcohol is also important for some long-acting forms: the Metadate CD, Jornay PM and Quillivant XR labels say to avoid alcohol because, in lab tests, it made the dose release faster.

How to take it

1. Typical dose
Your prescriber sets and adjusts the dose and picks the form. The Ritalin label starts children 6 and older at 5 mg twice daily (before breakfast and lunch), raised by 5 to 10 mg each week, and does not recommend more than 60 mg a day; adults average 20 to 30 mg a day in 2 or 3 doses, with a maximum of 60 mg a day. The Concerta label starts children 6 to 17 at 18 mg once daily, and adults at 18 mg or 36 mg once daily, raised by 18 mg each week to a maximum of 54 mg a day (ages 6 to 12) or 72 mg a day (ages 13 to 65). Doses in milligrams are not interchangeable between forms.
2. Higher studied dose
The Ritalin label does not recommend more than 60 mg a day. Concerta's maximum is 72 mg a day for people 13 to 65. The label says the risk of abuse rises with higher doses or unapproved ways of taking it, such as snorting or injection.
3. Timing
Immediate-release Ritalin: 2 or 3 times a day, preferably 30 to 45 minutes before meals, with the last dose before 6 p.m. if sleep is a problem. Concerta: once each morning. Jornay PM: in the evening. Follow the timing on your own product's label.
4. With food
Food has no relevant effect on Ritalin tablets or on Concerta, which can be taken with or without food. Concerta must be swallowed whole with liquid, never chewed, split or crushed. The Metadate CD, Jornay PM and Quillivant XR labels say to avoid alcohol, because it can make the dose release faster.
5. Split dosing
Immediate-release forms in 2 or 3 doses a day; long-acting forms once daily
6. How long to try
Long-term for many people, with regular check-ups. The label asks prescribers to reassess the risk of misuse throughout treatment, to check growth in children, and to stop the medicine if there is no improvement after a month of dose adjustment.

What to track

Blood pressure and pulse, especially after a dose change or when caffeine intake changes
Chest pain with exercise, fainting or a racing heart (contact a healthcare provider right away)
Sleep, appetite and, in children, height and weight
New tics, unusual mood changes, or seeing or hearing things that are not there
Fingers or toes that turn pale, blue or painful in the cold
Where the medicine is stored: locked away, with pills counted

Bottom line: A prescriber sets the dose and form; keep caffeine modest, avoid energy drinks and alcohol, and check any supplement with your pharmacist.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Decreased appetite and weight lossTrouble sleepingHeadacheStomach pain (the most common side effect of Concerta in children) and nauseaDry mouth, anxiety, irritability and dizzinessFast heartbeat and sweating

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Ritalin label says published studies and postmarketing reports have not identified a drug-associated risk of major birth defects, miscarriage or problems for the mother or baby. Stimulants can narrow blood vessels and may reduce blood flow to the placenta, and premature delivery and low birth weight have been reported in mothers dependent on amphetamine. A national pregnancy registry for ADHD medicines collects outcomes. Breastfeeding: limited data from seven mothers show methylphenidate passes into breast milk, giving infants 0.16% to 0.7% of the mother's weight-adjusted dose, with no reported adverse effects on the infant and no effect on milk production; the label asks that breastfed infants be watched for agitation, poor sleep, poor feeding and reduced weight gain.

Interactions

MAOIs (monoamine oxidase inhibitors)Critical

The label says methylphenidate is contraindicated with an MAOI or within 14 days after stopping one, because the combination can cause a hypertensive crisis, with possible outcomes including death, stroke, heart attack, aortic dissection and kidney failure. Make sure every prescriber knows about both medicines.

Energy drinksHigh

Energy drinks contain caffeine and other stimulating ingredients. A 2021 review of energy drink interactions says additive or greater effects of caffeine with other psychostimulants are expected, and that caffeine may enhance the heart-rate and blood-pressure effects of sympathomimetic (adrenaline-like) drugs; it names drugs such as amphetamines and cocaine but does not discuss methylphenidate, and no study of energy drinks with methylphenidate is cited. Methylphenidate already raises heart rate and blood pressure, according to its label. Avoid energy drinks while taking methylphenidate, keep other caffeine modest, and talk to your prescriber or pharmacist about how much is safe for you.

Halogenated anesthetics used for surgeryHigh

The label says these anesthetics combined with methylphenidate may raise the risk of a sudden rise in blood pressure and heart rate during surgery, and advises avoiding methylphenidate on the day of surgery in people receiving them. Tell your surgeon and anesthesia team that you take methylphenidate, and ask your prescriber how to handle the dose before surgery.

AlcoholHigh

The Metadate CD, Jornay PM and Quillivant XR labels say to avoid alcohol because it can speed up release of the dose; at 40% alcohol, Metadate CD released 84% of its methylphenidate in the first hour in lab testing. In small studies of healthy adults, alcohol also raised active d-methylphenidate levels (total exposure up 21% with immediate-release methylphenidate) and strengthened stimulant effects with short-acting and long-acting forms; heart rate was also higher with the short-acting form. Ask your prescriber about any drinking.

St. John's wort (Hypericum perforatum)Moderate

Evidence for this pair is thin. A study of US adverse event reports in children and adolescents (1997 to 2015) found two reports involving a methylphenidate product and St. John's wort in which an interaction was judged probable in one and possible in the other; report quality was poor, and the authors said more research is needed. The Metadate CD label says methylphenidate is broken down mainly by esterase enzymes and was not metabolized by cytochrome P450 enzymes in lab studies, so the liver-enzyme speed-up that St. John's wort causes with many drugs does not explain a possible interaction. Talk to your prescriber or pharmacist before adding St. John's wort or any mood supplement.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

See all 2 Methylphenidate interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Dispensed only on prescription; methylphenidate is a Schedule II controlled substance
Many forms that are not interchangeable milligram for milligram: immediate-release tablets and solution, once-daily tablets, capsules, chewables, liquids and dissolving tablets, an evening-dosed capsule (Jornay PM) and a skin patch (Daytrana)
Concerta tablets must be swallowed whole and are not chewed, split or crushed
The Metadate CD, Jornay PM and Quillivant XR labels say to avoid alcohol because, in lab tests, it sped up release of the dose

Be skeptical of…

"Study drugs" or ADHD pills sold online without a prescription
Supplements marketed as a "natural Ritalin" or as safe to stack with prescription stimulants
Pre-workout or energy products with high caffeine or other stimulants marketed alongside ADHD medicines
Advice to crush, chew or snort tablets for a stronger effect: the boxed warning says unapproved ways of taking it raise the risk of overdose and death

Frequently asked questions

Can I drink energy drinks while taking methylphenidate?⌄

It is best to avoid them. Energy drinks add caffeine and other stimulants on top of a medicine that already raises heart rate and blood pressure, and a review of energy drink interactions expects their effects to add up with stimulant drugs. Ask your prescriber how much caffeine is reasonable for you.

Is coffee okay with methylphenidate?⌄

Our database lists energy drinks, not coffee, as an interaction. Caffeine from any source adds stimulation, so keep it modest, watch for a racing heart, jitteriness or poor sleep, and ask your doctor or pharmacist what amount suits you.

Can I take St. John's wort with methylphenidate?⌄

Talk to your prescriber first. The evidence is limited to a small number of adverse event reports in children and adolescents, where an interaction was judged probable in one case and possible in another, and the cause is not explained by how methylphenidate is broken down. If you are looking for help with mood, your prescriber can discuss options.

Can I drink alcohol while taking methylphenidate?⌄

The Metadate CD, Jornay PM and Quillivant XR labels say to avoid alcohol, because in lab tests alcohol made the dose release faster. The Concerta label reports that alcohol up to 40% did not speed up release in the first hour in a lab test. Ask your pharmacist what your own product's label says.

Why does methylphenidate have a boxed warning?⌄

Because it has a high potential for abuse and misuse, which can lead to addiction, overdose and death, especially at higher doses or when snorted or injected. Store it locked away, never share it, and talk to your prescriber if you are worried about misuse.

References by claim

ADHD in children and adolescents

Cortese et al., 2018 · PMC (2018) link

Storebø et al., 2025 · PMC (2025) link

ADHD in adults

Cândido et al., 2021 · PMC (2021) link

Safety

Ritalin (methylphenidate HCl) prescribing information · DailyMed (FDA label) link

Concerta (methylphenidate HCl extended-release) prescribing information · DailyMed (FDA label) link

Daytrana (methylphenidate transdermal system) prescribing information · DailyMed (FDA label) link

Interaction: Energy drinks

Hladun et al., 2021 · PMC (2021) link

Interaction: St. John's wort (Hypericum perforatum)

Mazhar et al., 2020 · PubMed (2020) link

Metadate CD (methylphenidate HCl extended-release capsules) prescribing information · DailyMed (FDA label) link

Interaction: Alcohol

Jornay PM (methylphenidate hydrochloride extended-release) prescribing information · DailyMed (FDA label) link

Quillivant XR (methylphenidate hydrochloride extended-release oral suspension) prescribing information · DailyMed (FDA label) link

Patrick et al., 2013 · PMC (2013) link

Zhu et al., 2017 · PMC (2017) link

Track Methylphenidate with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.